Detalhe da pesquisa
1.
Heart rate decrease during crizotinib treatment and potential correlation to clinical response.
Cancer
; 119(11): 1969-75, 2013 Jun 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-23505007
2.
Asymptomatic profound sinus bradycardia (heart rate ≤45) in non-small cell lung cancer patients treated with crizotinib.
J Thorac Oncol
; 6(12): 2135-7, 2011 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-22088989
3.
Activity of crizotinib (PF02341066), a dual mesenchymal-epithelial transition (MET) and anaplastic lymphoma kinase (ALK) inhibitor, in a non-small cell lung cancer patient with de novo MET amplification.
J Thorac Oncol
; 6(5): 942-6, 2011 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-21623265